Self-control and its relation to joint developmental trajectories of cannabis use and depressive mood symptoms.

Drug and Alcohol Dependence
Roy OttenRutger C M E Engels

Abstract

Cannabis use and depressive mood symptoms in adolescence have been found to co-occur. In exploring the nature of this relationship and in the search for mechanisms that explain this link, scholars have postulated the idea for a 'common liability model'. According to this model, the link between cannabis use and depressive symptoms can be explained by an underlying risk factor. One important candidate for this underlying risk factor may be self-control, as a reflection of immature self-regulatory systems in adolescence. In the present study, we will test the extent to which joint development of cannabis use and depressive symptoms can be explained as an expression of self-control. A total of 428 adolescents participated in a five-wave longitudinal design. Main study outcomes were self-reports of self-control (age 12) and cannabis use and depressive symptoms (ages 12-16). We established six trajectories of joint development of cannabis use and depressive symptoms. Conditional probabilities indicated that cannabis use and depressive symptoms were symmetrically related. Levels of self-control were lowest for adolescents following the joint developmental pathway of cannabis use and high depressive symptoms. Low levels of self-contro...Continue Reading

References

Mar 1, 1986·Archives of General Psychiatry·D B Kandel, M Davies
Jul 1, 1974·Archives of General Psychiatry·P F RenaultD N de Mello
Oct 1, 1982·Archives of General Psychiatry·D B Kandel, M Davies
Mar 1, 1997·Addiction·D M Fergusson, L J Horwood
Dec 1, 2001·The American Journal of Psychiatry·G B Bovasso
Aug 30, 2002·Addiction·David M FergussonNicola Swain-Campbell
Nov 26, 2002·BMJ : British Medical Journal·Louise ArseneaultTerrie E Moffitt
Jun 25, 2003·Drug and Alcohol Dependence·Louisa DegenhardtMichael Lynskey
Mar 16, 2004·Journal of Personality·June P TangneyAngie Luzio Boone
Jun 3, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Deepak Cyril D'SouzaJohn Harrison Krystal
Jul 15, 2004·Annals of the New York Academy of Sciences·Jay N Giedd
Jul 15, 2004·Annals of the New York Academy of Sciences·Ronald E Dahl
Mar 24, 2005·Psychosomatic Medicine·Daniel RodriguezJanet Audrain-McGovern
May 28, 2005·Addiction·Zeena HarakehRutger C M E Engels
Sep 28, 2005·Addiction·Haske van der VorstJan Van Leeuwe
Nov 3, 2005·Development and Psychopathology·Erika E Forbes, Ronald E Dahl
Feb 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Karin MonshouwerWilma Vollebergh
Jun 24, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Adriana GalvanB J Casey
May 9, 2007·Archives of General Psychiatry·Edward D BarkerRichard E Tremblay
Jun 16, 2007·Neuroscience and Biobehavioral Reviews·Christopher G DaveyNicholas B Allen
Feb 28, 2008·European Child & Adolescent Psychiatry·Géraldine DorardCatherine Bungener
May 14, 2008·Developmental Psychology·Regina J J M van den EijndenRutger C M E Engels
May 16, 2008·Appetite·Roeline KuijerRuud van den Bos
Nov 21, 2009·Drug and Alcohol Dependence·Naomi R MarmorsteinStephen M Malone
Mar 6, 2010·Psychology & Health·R OttenR J J M Van den Eijnden
Mar 10, 2010·Developmental Psychology·Mara BrendgenFrank Vitaro

❮ Previous
Next ❯

Citations

Apr 4, 2012·International Journal of Environmental Research and Public Health·Kenneth W GriffinGilbert J Botvin
Jan 1, 2013·International Journal of High Risk Behaviors & Addiction·Kolthoum TayyebiNader Monirpoor
Jun 28, 2014·International Journal of High Risk Behaviors & Addiction·Abbas Abolghasemi, Saeed Rajabi
Feb 23, 2012·European Child & Adolescent Psychiatry·Patricia A M van DeurzenDorine I E Slaats-Willemse
Mar 28, 2012·Biological Psychiatry·John C ChurchwellDeborah A Yurgelun-Todd
Jun 27, 2014·Journal of Abnormal Child Psychology·Andrea L BarrocasJohn R Z Abela
Aug 15, 2014·Journal of Clinical and Experimental Neuropsychology·Stephan C J HuijbregtsHanna Swaab
Jul 14, 2020·International Journal of Public Health·Magda JavakhishviliKaraman Pagava

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.